إسرائيل - الإنجليزية - Ministry of Health

bayer israel ltd - drospirenone; ethinylestradiol as betadex clathrate; levomefolate calcium; levomefolate calcium - film coated tablets - levomefolate calcium 0.451 mg; ethinylestradiol as betadex clathrate 0.03 mg; drospirenone 3 mg; levomefolate calcium 0.451 mg - estradiol, combinations - oral contraceptive. in women who choose to use an oral contraceptive as their method of contraception, to raise folate levels for the purpose of reducing the risk of a neural tube defect in a pregnancy conceived while taking the product or shortly after discontinuing the product.

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

rowex ltd - fentanyl - transdermal patch - 25 microgram

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

rowex ltd - fentanyl - transdermal patch - 50 microgram

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

rowex ltd - fentanyl - transdermal patch - 75 microgram

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

rowex ltd - fentanyl - transdermal patch - 100 microgram

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

rowex ltd - fentanyl - transdermal patch - 50 microgram

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

rowex ltd - fentanyl - transdermal patch - 75 microgram

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

rowex ltd - fentanyl - transdermal patch - 100 microgram

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

rowex ltd - fentanyl - transdermal patch - 25 microgram

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

siga technologies, inc. - tecovirimat (unii: f925rr824r) (tecovirimat - unii:f925rr824r) - tpoxx® is indicated for the treatment of human smallpox disease caused by variola virus in adults and pediatric patients weighing at least 3 kg. the effectiveness of tpoxx for treatment of smallpox disease has not been determined in humans because adequate and well-controlled field trials have not been feasible, and inducing smallpox disease in humans to study the drug’s efficacy is not ethical [see clinical studies (14)] . tpoxx efficacy may be reduced in immunocompromised patients based on studies demonstrating reduced efficacy in immunocompromised animal models. tpoxx capsules: none. tpoxx injection: the excipient hydroxypropyl-β-cyclodextrin is eliminated through glomerular filtration. therefore, tpoxx injection is contraindicated in patients with severe renal impairment (defined as creatinine clearance below 30 ml/min) [see warnings and precautions (5.2) and use in specific populations (8.6)] . risk summary there are no available data on the use of tecovirimat in pregnant individuals to evaluate for a